CDC occupation Codes used to code ( map ) facility locations
|
|
|
- Clyde Gilbert Peters
- 10 years ago
- Views:
Transcription
1 CDC occupation Codes used to code ( map ) facility locations CDC (occupation) Code BLS SOC (2000)* CDC (occupation) Code BLS SOC (2000)* ATT-Attendant/orderly CLA-Clerical/administrative CNA-Nurse Anesthetist CNM-Nurse Midwife CSS-Central Supply CSW-Counselor/Social Worker DIT-Dietician DNA-Dental Assistant/Tech DNH-Dental Hygienist DNO-Other Dental Worker DNT-Dentist DST-Dental Student EMT-EMT/Paramedic FEL-Fellow FOS-Food Service HEM-Hemodialysis Technician HSK-Housekeeper ICP-Infection Control Professional IVT-IVT Team Staff LAU-Laundry Staff LPN-Licensed Practical Nurse MLT -Medical Laboratory Technician MNT-Maintenance/Engineering MOR-Morgue Technician MST-Medical Student MTE-Medical Technologist NUA-Nursing Assistant NUP-Nurse Practitioner OAS-Other Ancillary Staff OFR-Other First Responder OH-Occupational Health Professional OMS-Other Medical Staff ORS-OR/Surgery Technician Last Updated January 1,
2 CDC (occupation) Code OTH-Other BLS SOC (2000)* * Bureau of Labor Statistics (BLS) Standard Occupational Codes (SOC), available online at the United States Department of Labor, Bureau of Labor Statistics at OTT-Other Technician/Therapist PAS-Physician Assistant PCT-Patient Care Technician PHA-Pharmacist PHL-Phlebotomist/IV Team PHW-Public Health Worker PHY-Physician PLT-Physical Therapist PSY-Psychiatric Technician RCH-Researcher RDT-Radiologic Technologist RES-Intern/Resident RNU-Registered Nurse RTT-Respiratory Therapist/Tech STU-Other Student TRA-Transport/Messenger/Porter VOL-Volunteer Last Updated January 1,
3 CDC Device description used to code ( map ) medical devices used in the facility CDC Device Description IVPER - IV catheter - peripheral IVCATH - IV catheter central line HYPO - Hypodermic needle, attached syringe UNATT - Unattached hypodermic needle PREFILL - Prefilled cartridge syringe STYLET - I.V. Stylet VHOLD - Vacuum tube holder/needle SPINAL - Spinal or epidural needle BMARROW - Bone marrow needle BIOPSY - Biopsy needle OTH-HOL - Other hollow-bore needle UNK-HOL - Hollow-bore needle, type unknown HUBER - Huber needle WINGED - Winged-steel (Butterfly -type) needle HEMODIAL - Hemodialysis needle HYPO-TUB - Hypodermic, attached to IV tubing DENTASP -Dental aspirating syringe with needle ABCD - Arterial Blood Collection Device SUTR - Suture needle CDC Device Description BCUT - Bone cutter BOVIE - Electrocautery device BUR - Bur ELEV - Elevator EXPL - Explorer FILE - File FORCEPS - Extraction Forceps LANCET - Lancet MICRO - Microtome blade PIN - Pin RAZOR - Razor RETRACT - Retractor ROD - Rod (orthopaedic) SCALE - Scaler/curette SCALPEL - Scalpel blade SCIS - Scissors TENAC - Tenaculum TROCAR - Trocar WIRE - Wire Last Updated January 1,
4 CDC Device Description COLLTUBE - Blood collection tubes CAPILL - Capillary tube MED - Medication ampule/vial/iv bottle PIPE - Pipette (glass) SLIDE - Slide TUBE - Specimen/test/vacuum tube BCADAP - Blood culture adapter IVDEL - IV Delivery System CATHSECD - Catheter Securement Device PCOLLTUBE - Blood collection tubes - plastic PCAPILL - Capillary tube - plastic PTUBE - Specimen/test/vacuum tube - plastic UNK - Unknown type of sharp object OTHER - Other sharp Last Updated January 1,
5 Antiretroviral and Associated Drug Codes for Use on Healthcare Worker BBF Postexposure Prophylaxis form (CDC ) CDC Drug Code 3TC - lamivudine ABC - abacavir ATV - atazanavir CD4 - CD4 therapies D4T - stavudine ddi - didanosine DLV - delavirdine DRV - darunavir EFV - efavirenz ENF - enfuvirtide (T-20) ETR - etravirine fapv - fosamprenavir FTC - emtricitabine HU - hydroxyurea IDV - indinavir IL2 - interleukin2 INT - interferon LPV - lopinavir Last Updated January 1,
6 NFV - nelfinavir NVP - nevirapine OTH - other RLT - raltegravir RIL - Rilpivirine RTV - ritonavir SQV - saquinavir TDF - tenofovir TIP - tipranavir (PNU ) ZDV - zidovudine (AZT) Last Updated January 1,
Comprehensive Case Management Reassessment
Comprehensive Case Management Reassessment Reassessment Date: Date of previous Assessment/Reassessment: Name: Client ID # Address: If Reassessment early or late explain: Current HIV Status: Asymptomatic
HIV Update: Epidemiology and Pathophysiology
HIV Update: Epidemiology and Pathophysiology MATEC Michigan AIDS Research and Education Center Wayne State University School of Medicine (313) 962-2000 matecmichigan.org 1 Epidemiology of the Epidemic:
1/26/2015. Epidemiology of the Epidemic: World. Epidemiology of the Epidemic: United States. HIV Update: Epidemiology and Pathophysiology
HIV Update: Epidemiology and Pathophysiology MATEC Michigan AIDS Research and Education Center Wayne State University School of Medicine (313) 962-2000 matecmichigan.org Epidemiology of the Epidemic: World
HIV MEDICATIONS AT A GLANCE. Atripla 600/200/300 mg tablet 02300699 1 tablet daily. Complera 200/25/300 mg tablet 02374129 1 tablet daily
HIV MEDICATIONS AT A GLANCE Generic Name Trade Name Strength DIN Usual Dosage Single Tablet Regimen (STR) Products Efavirenz/ emtricitabine/ Emtricitabine/ rilpivirine/ elvitegravir/ cobicistat/ emtricitabine/
GENERAL INSTRUCTIONS FOR COMPLETING THE HIV TEST FORM
GENERA INSTRUCTIONS FOR COMPETING THE This form is designed to be read by an Optical Character Recognition (OCR) scanner. The legibility of this form depends on the quality of the a hand written and selected
FARMACI, INNOVAZIONE e INFEZIONE DA HIV / AIDS
FARMACI, INNOVAZIONE e INFEZIONE DA HIV / AIDS Stefano Vella Dipartimento del Farmaco Istituto Superiore di Sanità - Roma Stages of HIV-1 Life Cycle Targeted by Anti-HIV Drugs In: Gulick RM, Topics HIV
Theonest Ndyetabura KILIMANJARO CHRISTIAN MEDICAL CENTRE / KILIMANJARO CLINICAL RESERCH
TREATMENT FAILURE AND PATTERNS OF GENOTYPIC DRUG RESISTANCE MUTATIONS AMONG HAART EXPERIENCED HIV-1 PATIENTS AT KCMC Theonest Ndyetabura KILIMANJARO CHRISTIAN MEDICAL CENTRE / KILIMANJARO CLINICAL RESERCH
HIV 1. A reference guide for prescription HIV-1 medications
HIV 1 A reference guide for prescription HIV-1 medications Several different kinds of antiretroviral drugs are currently used to treat HIV-1 infection. These medicines are the ones most commonly used in
Generic antiretrovirals in Europe: a blessing or a curse?
Generic antiretrovirals in Europe: a blessing or a curse? Ricardo Jorge Camacho 1 Molecular Biology Laboratory, Centro Hospitalar de Lisboa Ocidental 2 Instituto de Higiene e Medicina Tropical, Universidade
Covered California s 2016 Formularies
Covered California s 2016 Formularies An analysis of the drugs per tier in all 12 health plans that are available for treating and preventing HIV (pp 1 24) and for treating hepatitis B (pp 26 37) and hepatitis
Chapter 3 South African guidelines and introduction to clinical cases
Chapter 3 South African guidelines and introduction to clinical cases 3.1. South African national antiretroviral guidelines When this book was published in 2012 the current national antiretroviral treatment
HIV and the Central Nervous System: neurocognitive aspects VIH y Sistema Nervioso Central: aspectos neurocognitivos
HIV and the Central Nervous System: neurocognitive aspects VIH y Sistema Nervioso Central: aspectos neurocognitivos Gabriele Arendt Department of Neurology, University Hospital of Duesseldorf (UKD) 40
862060_Rec Drug Guide.qxd 2/5/14 1:06 PM Page 1. Recreational Drugs and HIV Antiretrovirals. A Guide to Interactions for Clinicians
862060_Rec Drug Guide.qxd 2/5/14 1:06 PM Page 1 Recreational Drugs and HIV Antiretrovirals A Guide to Interactions for Clinicians 2014 862060_Rec Drug Guide.qxd 2/5/14 1:06 PM Page 2 Recreational Drugs
HIV Post Exposure Prophylaxis Update
HIV Post Exposure Prophylaxis Update Mary Goodspeed, RN, BS 716-898-4713 Coordinator, HIV Clinical Education Initiative Erie County Medical Center, Buffalo, NY PEP Hotline 1-888-448-4911 www.aidscenterecmc.org
Drug Treatment Program Update
Drug Treatment Program Update As of May 211 Drug Treatment Program Update A key component of the Centre s mandate is to monitor the impact of HIV/AIDS on British Columbia. The Centre provides essential
Presented by: Canadian Working Group on HIV and Rehabilitation
Rehabilitation in the Context of HIV: An Interprofessional Course for Occupational Therapists, Physiotherapists, Speech-Language Pathologists and Audiologists Presented by: Canadian Working Group on HIV
Antiretroviral therapy for HIV infection in infants and children: Towards universal access
Antiretroviral therapy for HIV infection in infants and children: Towards universal access Executive summary of recommendations Preliminary version for program planning 2010 Executive summary Tremendous
UPDATE IN HIV POST-EXPOSURE PROPHYLAXIS. Weerawat Manosuthi
UPDATE IN HIV POST-EXPOSURE PROPHYLAXIS Weerawat Manosuthi Outline Case scenario of postexposure prophylaxis Risks of and how to manage postexposure prophylaxis Current PEP guideline US PHS 2013 New York
Use and Disposal of Sharps
From Infection Prevention: A Reference Booklet for Health Care Providers 2001 EngenderHealth Use and Disposal of Sharps In health care settings, injuries from needles and other sharp items are the number-one
The Antiretroviral. Pregnancy Registry. Interim Report VOL. 28, NO. 1 1 JANUARY 1989 THROUGH 31 JANUARY 2016. Interim Report. (Issued: June 2016)
The Antiretroviral The Antiretroviral Pregnancy Registry Pregnancy Registry Interim Report VOL. 28, NO. 1 1 JANUARY 1989 THROUGH 31 JANUARY 2016 Interim Report (Issued: June 2016) VOL. (Expiration: 28,
People living. Since the start of the AIDS epidemic, more than 78 million people have been infected with HIV and 39 million have died (1).
THE GAP REPORT 2014 People living with HIV Since the start of the AIDS epidemic, more than 78 million people have been infected with HIV and 39 million have died (1). Acquiring HIV no longer means certain
Combination Anti-Retroviral Therapy (CART) - Rationale and Recommendation. M Dinaker. Fig.1: Effect of CART on CD4 and viral load
Combination Anti-Retroviral Therapy (CART) - Rationale and Recommendation M Dinaker INTRODUCTION The wide availability of effective, safe and mostly well tolerated combined anti-retroviral therapy (CART)
LIQUID DRUG FORMULATIONS. Formulation Status Cost Comments. facilitated access
LIQUID DRUG FORMULATIONS Drug ANTIRETROVIRALS FIXED DOSE COMBINATION PRODUCTS Atripla (efavirenz/ emtricitabine/ tenofovir) No Atripla FDC tablet crushed, dissolved in 5 ml of water and diluted to 20 ml
Helpful HIV Medication Tables for Pharmacists
861837_Pharmguide.qxd 2/5/14 12:55 PM Page 1 Helpful HIV Medication Tables for Pharmacists New York/New Jersey AIDS Education & Training Center (AETC) www.nynjaetc.org Winter 2014 861837_Pharmguide.qxd
NON-OCCUPATIONAL POST EXPOSURE PROPHYLAXIS FOR SEXUAL ASSAULT SURVIVORS. Carl LeBuhn, MD
NON-OCCUPATIONAL POST EXPOSURE PROPHYLAXIS FOR SEXUAL ASSAULT SURVIVORS Carl LeBuhn, MD Post-Exposure Prophylaxis (PEP) The use of therapeutic agents to prevent infection following exposure to a pathogen
Republic of Namibia. Ministry of Health and Social Services Directorate of Special Programmes
Republic of Namibia Ministry of Health and Social Services Directorate of Special Programmes National Guidelines for Antiretroviral Therapy Fourth Edition January 2014 Enquiries: [email protected] 1 Foreword
Treatment Information Service 1 800 HIV 0440 HIV/AIDS. HIV and Its Treatment What You Should Know. 2nd edition
HIV/AIDS Treatment Information Service 1 800 HIV 0440 HIV and Its Treatment What You Should Know 2nd edition HIV/AIDS TREATMENT INFORMATION SERVICE 2nd Edition HIV and Its Treatment: What You Should Know
AIDS ACCESS FOUNDATION/ MSF AIDS can be Treated: A handbook of Antiretroviral medicines. AIDS Can Be Treated. A Hand Book of Antiretroviral medicines
AIDS Can Be Treated A Hand Book of Antiretroviral medicines The translation of this booklet is due to support from the Working Together Regional Training Project of the AIDS Access Foundation, Bangkok
ACA Insurance Enrollment for People living with HIV in North Carolina
ACA Insurance Enrollment for People living with HIV in North Carolina A Guide for the HIV Community In 2015, people living with HIV should take a fresh look at the insurance marketplace. Coverage will
Treatment 2.0 as a catalyst for Tasp through Drug / Treatment Optimization
Treatment 2.0 as a catalyst for Tasp through Drug / Treatment Optimization STEFANO VELLA MD ISTITUTO SUPERIORE DI SANITÀ ROME - ITALY DDF 6 WAFAA EL SADR, CROI 2012 The problem is in how to efficiently
ACT. Advocacy for Community Treatment ITPC. Strengthening Community Responses to HIV Treatment and Prevention
ACT toolkit Advocacy for Community Treatment Strengthening Community Responses to HIV Treatment and Prevention ITPC INTERNATIONAL TREATMENT PREPAREDNESS COALITION July 2014 About ITPC ITPC is a worldwide
Drug-Drug Interactions Among Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Medications
Infect Dis Ther (2015) 4:159 172 DOI 10.1007/s40121-015-0061-2 REVIEW Drug-Drug Interactions Among Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Kirpal Kaur. Mona A. Gandhi. Judianne Slish
North Carolina Marketplace Plans with More Affordable Drug Cost Sharing for People with HIV
North Carolina Marketplace Plans with More Affordable Drug Cost Sharing for People with HIV Of North Carolina s marketplace insurance offerings, only Blue Cross Blue Shield s plans are potentially affordable
Review When Patients Cannot Take Pills: Antiretroviral Drug Formulations for Managing Adult HIV Infection
IAS USA Topics in Antiviral Medicine Review When Patients Cannot Take Pills: Antiretroviral Drug Formulations for Managing Adult HIV Infection Chessa R. Nyberg, PharmD, Brooke Y. Patterson, PharmD, and
Prioritizing Second-Line Antiretroviral Drugs for Adults and Adolescents: a Public Health Approach
Prioritizing Second-Line Antiretroviral Drugs for Adults and Adolescents: a Public Health Approach Report of a WHO Working Group Meeting World Health Organization HIV Department Geneva, Switzerland 21-22
Pharmacoprevention. HIV-drugs for prevention. Instituut Tropische Geneeskunde, Antwerpen
Pharmacoprevention HIV-drugs for prevention Instituut Tropische Geneeskunde, Antwerpen Introduction Afkortingskunde: What s in a name/ abbreviation? PEP PrEP TASP PMTCT Introduction PEP: Post-Exposure
Management of HIV and TB Co-infection in South Africa
Management of HIV and TB Co-infection in South Africa Halima Dawood Department of Medicine Case Report 39 yr old female Referred to clinic on 14/06/2006 for consideration to commence antiretroviral therapy
Access and coverage of antiretroviral drugs through Canada s provincial and territorial drug programs
Access and coverage of antiretroviral drugs through Canada s provincial and territorial drug programs Provinces/Territory Drug Dose Form Alberta British Columbia Manitoba New Brunswick Newfoundland & Labrador
Marketplace Health Plans Template Assessment Tool October 2014
Marketplace Health Plans Template Assessment Tool October 2014 Beginning in January 2015, state and federal Marketplaces (aka exchanges) will again offer a range of insurance plans called qualified health
Systematic literature search: PICO questions
BHIVA Treatment Guidelines 2014: Systematic literature search questions Page 1 of 5 Systematic literature search: PICO questions 2.1 Questions and PICO criteria Databases: Medline, Embase, Cochrane Library,
Health Care Worker Health and Safety: Preventing Needlestick Injury and Occupational Exposure to Bloodborne Pathogens
Health Care Worker Health and Safety: Preventing Needlestick Injury and Occupational Exposure to Bloodborne Pathogens World Health Organization International Council of Nurses WHO-ICN Project Preventing
Procurement Cost Trends for Global Fund Commodities
Procurement Cost Trends for Global Fund Commodities Analysis of Trends for Selected Commodities 2005 2012 By Frank Wafula, Ambrose Agweyu and Kate Macintyre Aidspan Working Paper 02/2013, April 2013 P.O.
Antiretroviral Treatment
Antiretroviral Treatment Michael A. Tolle, MD, MPH Heidi Schwarzwald, MD, MPH Nancy R. Calles, MSN, PNP, ACRN, MPH Objectives 1. Discuss the goals of treatment for human immunodeficiency virus (HIV) infection.
HIV & Malignancy Potential for Drug Drug Interactions
HIV & Malignancy Potential for Drug Drug Interactions Kay Seden Aims and Outline Mechanisms of drug drug interactions associated with antiretrovirals and treatment for malignancy Examples of interactions
Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis
Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), and Human Immunodeficiency
National Antiretroviral Treatment Guidelines for Adults, Adolescents, and Children
Ministry of Health National Antiretroviral Treatment Guidelines for Adults, Adolescents, and Children Edited by: Elly T. Katabira, FRCP Moses R. Kamya, M. Med, MPH, PhD Israel Kalyesubula, M. Med, DTCH
Prevalenza HIV/HCV in Italia
Prevalence of HIV/HCV co-infection by region, 2013 WHO global systematic review of prevalence of HIV/HCV Ab co-infection based on prevalence studies in HIV+ persons stratified by risk group (where available)
POSTEXPOSURE PROPHYLAXIS
POSTEXPOSURE PROPHYLAXIS Bloodborne viruses Hepatitis B Hepatitis C HIV Hepatitis B Risk of seroconversion HBeAg negative 2% HBeAg positive 20-40% If seroconvert most recover completely and develop immunity
Management of Substance Abuse
Chapter : Management of Substance Abuse Chapter : Management of Substance Abuse Henry Francis, MD ASSESSMENT OF SUBSTANCE ABUSE PROBLEMS TREATMENT OF SUBSTANCE ABUSE PROBLEMS MEDICAL AND PAIN MANAGEMENT
Antiretroviral Treatment Options for Patients on Directly Acting Antivirals for Hepatitis C. Daclatasvir (Daklinza, DCV, BMS-790052)
Antiretroviral Treatment Options for Patients on Directly Acting Antivirals for Hepatitis C PIs: atazanavir PIs: other Simeprevir with ritonavir- or cobicistat boosted PIs (significant simeprevir AUC).
THE SOUTH AFRICAN ANTIRETROVIRAL TREATMENT GUIDELINES 2013
THE SOUTH AFRICAN ANTIRETROVIRAL TREATMENT GUIDELINES 2013 VERSION 14 March 2013 Contents Acronym glossary... 2 1. Goals of the programme... 3 2. Objectives... 3 3. Specific Objectives... 3 4. Adults and
Myths and Realities on Prices of AIDS Drugs
White Paper Myths and Realities on Prices of AIDS Drugs by Carol C. Adelman, Dr.P.H., Senior Fellow Jeremiah Norris, Adjunct Fellow S. Jean Weicher, Research Assistant Introduction: The introduction of
Meeting Report 15 th PK Workshop, Washington, 2014 Produced by www.hiv-druginteractions.org
Page 1 of 7 HIV Interaction Studies presented at the 15 th International Workshop on Clinical Pharmacology of HIV and HCV Therapy, Washington, April 2014. This report summarises interaction studies relating
Post-Exposure Prophylaxis after Non-Occupational and Occupational exposure to HIV. National Guidelines
Post-Exposure Prophylaxis after Non-Occupational and Occupational exposure to HIV National Guidelines National guidelines for post-exposure prophylaxis after non-occupational and occupational exposure
Prevention of Injury at Work: Promoting Staff Health and Psychological Well-being. Susan Goodwin Gerberich, PhD University of Minnesota, USA
Prevention of Injury at Work: Promoting Staff Health and Psychological Well-being Susan Goodwin Gerberich, PhD University of Minnesota, USA OVERVIEW Healthcare Workforce: Globally and in the United States
Sharps Injury Surveillance
IntroOne 4/23/09 11:30 AM Page i Sharps Injury Surveillance MANUAL Occupational Health Unit Ministry of Health Malaysia 2007 IntroOne 4/23/09 11:30 AM Page ii IntroOne 4/23/09 11:30 AM Page iii Contents
Guidelines for Antiretroviral Therapy
Guidelines for Antiretroviral Therapy for the Prevention and Treatment of HIV in Zimbabwe National Medicine and Therapeutics Policy Advisory Committee (NMTPAC) and The AIDS and TB Directorate, Ministry
Antiretroviral Patient Medication Information Sheets Table of Contents
Antiretroviral Patient Medication Information Sheets Table of Contents 1. About this Resource, Disclaimer, Instructions for Use 2. General information sheet - Provide this to all patients 3. Drug Specific
Connecticut Biomedical Waste (BMW) Requirements (22a-209-15) and Common Industry Practices
Connecticut Biomedical Waste (BMW) Requirements (22a-209-15) and Common Industry Practices Mark Latham CT DEP, Waste Engineering and Enforcement Division Common Synonyms for BMW Regulated Medical Waste
American Nurses Association s. Needlestick Prevention Guide
American Nurses Association s Needlestick Prevention Guide American Nurses Association s Needlestick Prevention Guide Supported by an unrestricted educational grant from B-D, Inc. (Becton-Dickinson). 2002
Provide chairside support during the extraction of teeth and minor oral surgery
About this workforce competence This workforce competence is intended for those who provide close support during the extraction of erupted teeth, the extraction of unerupted teeth or roots, and bone removal.
The prevalence of transmitted antiretroviral drug resistance in treatment-naïve patients and factors influencing firstline treatment regimen selection
DOI: 10.1111/j.1468-1293.2008.00561.x r 2008 Merck & Co., Inc. HIV Medicine (2008), 9, 285 293 ORIGINAL RESEARCH The prevalence of transmitted antiretroviral drug resistance in treatment-naïve patients
American Nurses Association s. Needlestick Prevention Guide
American Nurses Association s Needlestick Prevention Guide American Nurses Association s Needlestick Prevention Guide Supported by an unrestricted educational grant from B-D, Inc. (Becton-Dickinson). 2002
Blood/Bodily Fluid Exposure and Needlestick Injury Policy Statement & HIV PEP Kit Dispensing Guideline
Blood/Bodily Fluid Exposure and Needlestick Injury Policy Statement & HIV PEP Kit Dispensing Guideline Providing certain services in a pharmacy, especially injections, carries a risk for the pharmacist
Anesthesia Products Needles. Anesthesia Products Trays. Antimicrobial Products. Hypodermic/Diabetes Care Products. Hypodermic/Reusable Products
2014 2015 Sections A1 A2 B C D E F G H I J K L M Anesthesia Products Needles Anesthesia Products Trays Antimicrobial Products Flush Products Hypodermic/Diabetes Care Products Hypodermic/Reusable Products
Regulatory Approach in Germany and in the EU to Fixed Dose Combination Medicinal Products Using HIV/AIDS Treatment as an Example
Regulatory Approach in Germany and in the EU to Fixed Dose Combination Medicinal Products Using HIV/AIDS Treatment as an Example Prof. Dr. rer. nat. habil. Harald G. Schweim President Federal Institute
Chemotherapy regimen: Dose adjusted EPOCH
Chemotherapy regimen: Dose adjusted EPOCH Agents involved Etoposide 50 mg/m 2 /d continuous IV infusion D 1 4 Doxorubicin 10 mg/m 2 /d continuous IV infusion D 1 4 Vincristine 0.4 mg/m 2 /d IV continuous
NATIONAL GUIDELINES FOR HIV AND AIDS TREATMENT AND CARE IN ADOLESCENTS AND ADULTS
NATIONAL GUIDELINES FOR HIV AND AIDS TREATMENT AND CARE IN ADOLESCENTS AND ADULTS FEDERAL MINISTRY OF HEALTH ABUJA NIGERIA LIST OF CONTRIBUTORS OCTOBER 2010 LIST OF CONTRIBUTORS FMOH 1 Mr. Linus Awute